Emerging respiratory tract infections

The Lancet Infectious Diseases

Volumn 14, Issue 10, 2014, Pages 910-911

  Zumla, Alimuddin ^a,b,h   Hui, David S ^c   Al Tawfiq, Jaffar A ^d,e   Gautret, Phillipe ^f   McCloskey, Brian ^g,h   Memish, Ziad A ^h  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^d DHAHRAN HEALTH CENTER   (Saudi Arabia)

^e INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f HÔPITAL NORD   (France)

^g PUBLIC HEALTH ENGLAND   (United Kingdom)

^h MINISTRY OF HEALTH   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; VACCINE;

BACTERIAL INFECTION; DIAGNOSTIC TEST; DISEASE SURVEILLANCE; DISEASE TRANSMISSION; EPIDEMIC; GEOGRAPHIC DISTRIBUTION; HUMAN; NONHUMAN; NOTE; PANDEMIC; PATHOGENESIS; POINT OF CARE TESTING; RESPIRATORY TRACT INFECTION; RESPIRATORY VIRUS; VIRAL RESPIRATORY TRACT INFECTION; ANIMAL; ANTIBIOTIC RESISTANCE; COMMUNICABLE DISEASES, EMERGING; HEALTH; RESPIRATORY TRACT INFECTIONS; ZOONOSIS;

ANIMALS; ANTI-INFECTIVE AGENTS; COMMUNICABLE DISEASES, EMERGING; DRUG RESISTANCE, MICROBIAL; GLOBAL HEALTH; HUMANS; RESPIRATORY TRACT INFECTIONS; ZOONOSES;

EID: 84908126598     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(14)70899-0     Document Type: Note

References (16)

1. Zumla A, Yew WW, Hui DS Emerging respiratory infections in the 21st century. Preface. Infect Dis Clin North Am 2010, 24:13-16.
2. Lancet 2013, 384:53-63. The Lancet Infectious Diseases Commission on antibiotic resistance.
3. Fauci AS, Morens DM The perpetual challenge of infectious diseases. N Engl J Med 2012, 366:454-461.
4. World Development report 1993: Investing in health: world development indicator. Oxford University press, Oxford, UK. 1-346 World Bank, (accessed Aug 13, 2014). http://elibrary.worldbank.org/doi/pdf/10.1596/0-1952-0890-0.
5. Murray CJ, Lopez AD Measuring the global burden of diseases. N Eng J Med 2013, 369:448-457.
6. Morens DM, Folkers GK, Fauci AS Emerging infections: a perpetual challenge. Lancet Infect Dis 2008, 8:710-719.
7. Hui DS, Memish ZA, Zumla A Severe acute respiratory syndrome vs. the Middle East respiratory syndrome. Curr Opin Pulm Med 2014, 20:233-241.
8. Hon KL Severe respiratory syndromes: travel history matters. Travel Med Infect Dis 2013, 11:285-287.
9. Al-Tawfiq JA, Zumla A, Gautret P, et al. Surveillance for emerging respiratory viruses. Lancet Infec Dis 2014, published online Sept 2. http://dx.doi.org/10.1016/S1473-3099(14)70840-0.
10. McCloskey B, Dar O, Zumla A, Heymann DL Emerging Infectious diseases and pandemic potential: status quo and reducing risk of global spread. Lancet Infec Dis 2014, published online Sept 2. http://dx.doi.org/10.1016/S1473-3099(14)70846-1.
11. Gautret P, Gray GC, Charrel RN, et al. Emerging viral respiratory tract infections-environmental risk factors and transmission. Lancet Infec Dis 2014, published online Sept 2. http://dx.doi.org/10.1016/S1473-3099(14)70831-X.
12. Zumla A, Al-Tawfiq JA, Enne V, et al. Rapid point of care diagnostic tests for viral and bacterial respiratory tract infections-needs, advances, and future prospects. Lancet Infec Dis 2014, published online Sept 2. http://dx.doi.org/10.1016/S1473-3099(14)70827-8.
13. Zumla A, Memish ZA, Maeurer M, et al. Emerging novel and antimicrobial-resistant respiratory tract infections: new drug development and therapeutic options. Lancet Infec Dis 2014, published online Sept 2. http://dx.doi.org/10.1016/S1473-3099(14)70828-X.
14. Raina MacIntyre C The discrepant epidemiology of Middle East respiratory syndrome coronavirus (MERS-CoV). Environment Systems and Decisions 2014, published online July 25. 10.1007/s10669-014-9506-5.
15. McNabb SJ, Shaikh AT, Nuzzo JB, Zumla AI, Heymann DL Triumphs, trials, and tribulations of the global response to MERS coronavirus. Lancet Respir Med 2014, 2:436-437.
16. Gostin LO, Sridhar D global health and the Law. N Engl J Med 2014, 370:1732-1740.